Concerns regarding design, analysis, and interpretation of the morrison study on hormonal contraceptive use and acquisition of cervical infections
Warner, P.
Sexually Transmitted Diseases 32(10): 644; Author Reply 645
2005
ISSN/ISBN: 0148-5717 PMID: 16205308 DOI: 10.1097/01.olq.0000175374.98875.33Document Number: 256379
Document emailed within 0-6 h
Related Documents
Ralph, L.J.; McCoy, S.I.; Shiu, K.; Padian, N.S. 2015: Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies LANCET. Infectious Diseases 15(2): 181-189Wawer, M.J.; Gray, R.H. 2012: Challenges in assessing associations between hormonal contraceptive use and the risks of HIV-1 acquisition and transmission Future Microbiology 7(3): 315-318
Ralph, L.J.; Gollub, E.L.; Jones, H.E. 2015: Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data Current Opinion in Obstetrics and Gynecology 27(6): 487-495
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Kiweewa, F.M.; Brown, E.; Mishra, A.; Nair, G.; Palanee-Phillips, T.; Mgodi, N.; Nakabiito, C.; Chakhtoura, N.; Hillier, S.L.; Baeten, J.M.; Soto-Torres, L.; Schwartz, K.; Makanani, B.; Martinson, F.; Bekker, L.-G.; Govender, V.; Mhlanga, F. 2019: Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: a prospective Study among High-risk African Women Journal of the International Aids Society 22(2): E25257
Polis, C.B.; Phillips, S.J.; Curtis, K.M.; Westreich, D.J.; Steyn, P.S.; Raymond, E.; Hannaford, P.; Turner, A.N. 2014: Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence Contraception 90(4): 360-390
Polis, C.B.; Phillips, S.J.; Curtis, K.M.; Westreich, D.J.; Steyn, P.S.; Raymond, E.; Hannaford, P.; Turner, A.N. 2014: Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence Contraception 90(4): 360-390
Morrison, C.S.; Chen, P.-L.; Kwok, C.; Baeten, J.M.; Brown, J.; Crook, A.M.; Van Damme, L.; Delany-Moretlwe, S.; Francis, S.C.; Friedland, B.A.; Hayes, R.J.; Heffron, R.; Kapiga, S.; Karim, Q.A.; Karpoff, S.; Kaul, R.; McClelland, R.S.; McCormack, S.; McGrath, N.; Myer, L.; Rees, H.; van der Straten, A.; Watson-Jones, D.; van de Wijgert, J.H.H.M.; Stalter, R.; Low, N. 2015: Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis Plos Medicine 12(1): E1001778
Taylor, D. 2009: Issues in the design, analysis and interpretation of condom functionality studies Contraception 80(3): 237-244
Lee, Y.J.; Wesley, R.A. 1981: Statistical contributions to phase Ii trials in cancer: interpretation, analysis and design Seminars in Oncology 8(4): 403-416
Koch, J.P. 1982: The Prentif contraceptive cervical cap: acceptability aspects and their implications for future cap design Contraception 25(2): 161-173
Ashrafunnessa; Kamal, M. 2008: Cervical intraepithelial neoplasia and its relationship with hormonal contraceptive methods Bangladesh Medical Research Council Bulletin 34(1): 33-35
Baeten, J.M.; Nyange, P.M.; Richardson, B.A.; Lavreys, L.; Chohan, B.; Martin, H.L.; Mandaliya, K.; Ndinya-Achola, J.O.; Bwayo, J.J.; Kreiss, J.K. 2001: Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study American Journal of Obstetrics and Gynecology 185(2): 380-385
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Lavreys, L.; Chohan, V.; Overbaugh, J.; Hassan, W.; McClelland, R.Scott.; Kreiss, J.; Mandaliya, K.; Ndinya-Achola, J.; Baeten, J.M. 2004: Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women Aids 18(16): 2179-2184
1988: A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. I: Contraceptive efficacy and side effects Contraception (Stoneham) 37(1): 1-20
Grabowski, M.K.; Gray, R.H.; Makumbi, F.; Kagaayi, J.; Redd, A.D.; Kigozi, G.; Reynolds, S.J.; Nalugoda, F.; Lutalo, T.; Wawer, M.J.; Serwadda, D.; Quinn, T.C.; Tobian, A.A.R. 2015: Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda Lancet. Global Health 3(8): E478-E486
Leslie, H.H.; Karasek, D.A.; Harris, L.F.; Chang, E.; Abdulrahim, N.; Maloba, M.; Huchko, M.J. 2014: Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods PLOS one 9(6): E101090